263 related articles for article (PubMed ID: 22686732)
1. Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis.
Lorenzo N; Barberá A; Domínguez MC; Torres AM; Hernandez MV; Hernandez I; Gil R; Ancizar J; Garay H; Reyes O; Altruda F; Silengo L; Padrón G
Autoimmunity; 2012 Sep; 45(6):449-59. PubMed ID: 22686732
[TBL] [Abstract][Full Text] [Related]
2. An altered peptide ligand corresponding to a novel epitope from heat-shock protein 60 induces regulatory T cells and suppresses pathogenic response in an animal model of adjuvant-induced arthritis.
Dominguez Mdel C; Lorenzo N; Barbera A; Darrasse-Jeze G; Hernández MV; Torres A; Hernández I; Gil R; Klatzmann D; Padrón G
Autoimmunity; 2011 Sep; 44(6):471-82. PubMed ID: 21370936
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.
Prakken BJ; Roord S; van Kooten PJ; Wagenaar JP; van Eden W; Albani S; Wauben MH
Arthritis Rheum; 2002 Jul; 46(7):1937-46. PubMed ID: 12124879
[TBL] [Abstract][Full Text] [Related]
4. APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients.
Barberá A; Lorenzo N; Garrido G; Mazola Y; Falcón V; Torres AM; Hernández MI; Hernández MV; Margry B; de Groot AM; van Roon J; van der Zee R; Broere F; van Eden W; Padrón G; Domínguez Mdel C
Int Immunopharmacol; 2013 Dec; 17(4):1075-83. PubMed ID: 24177275
[TBL] [Abstract][Full Text] [Related]
5. APL-2, an altered peptide ligand derived from heat-shock protein 60, induces interleukin-10 in peripheral blood mononuclear cell derived from juvenile idiopathic arthritis patients and downregulates the inflammatory response in collagen-induced arthritis model.
Lorenzo N; Cantera D; Barberá A; Alonso A; Chall E; Franco L; Ancizar J; Nuñez Y; Altruda F; Silengo L; Padrón G; Del Carmen Dominguez M
Clin Exp Med; 2015 Feb; 15(1):31-9. PubMed ID: 24474501
[TBL] [Abstract][Full Text] [Related]
6. Altered collagen II peptides inhibited T-cell activation in rheumatoid arthritis.
Li R; Li X; Li Z
Clin Immunol; 2006; 118(2-3):317-23. PubMed ID: 16343992
[TBL] [Abstract][Full Text] [Related]
7. Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance.
Lu Y; Xiao J; Wu ZW; Wang ZM; Hu J; Fu HZ; Chen YY; Qian RQ
Phytomedicine; 2012 Jul; 19(10):882-9. PubMed ID: 22673798
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells.
Gonzalez-Rey E; Chorny A; Varela N; O'Valle F; Delgado M
Arthritis Rheum; 2007 Feb; 56(2):531-43. PubMed ID: 17265488
[TBL] [Abstract][Full Text] [Related]
9. Activation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis.
Tanaka S; Kimura Y; Mitani A; Yamamoto G; Nishimura H; Spallek R; Singh M; Noguchi T; Yoshikai Y
J Immunol; 1999 Nov; 163(10):5560-5. PubMed ID: 10553084
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation.
Magari K; Miyata S; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000
[TBL] [Abstract][Full Text] [Related]
11. Suppression of collagen-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of type II collagen.
Iizuka M; Wakasa Y; Tsuboi H; Asashima H; Hirota T; Kondo Y; Matsumoto I; Takaiwa F; Sumida T
Plant Biotechnol J; 2014 Oct; 12(8):1143-52. PubMed ID: 24989432
[TBL] [Abstract][Full Text] [Related]
12. APL-1, an altered peptide ligand derived from heat-shock protein, alone or combined with methotrexate attenuates murine collagen-induced arthritis.
Lorenzo N; Altruda F; Silengo L; Del Carmen Dominguez M
Clin Exp Med; 2017 May; 17(2):209-216. PubMed ID: 27160252
[TBL] [Abstract][Full Text] [Related]
13. Altered collagen II 263-272 peptide immunization induces inhibition of collagen-induced arthritis through a shift toward Th2-type response.
Li R; Li X; Li Z
Tissue Antigens; 2009 Apr; 73(4):341-7. PubMed ID: 19317744
[TBL] [Abstract][Full Text] [Related]
14. Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent.
Srinivasan M; Eri R; Zunt SL; Summerlin DJ; Brand DD; Blum JS
Arthritis Rheum; 2007 Feb; 56(2):498-508. PubMed ID: 17265485
[TBL] [Abstract][Full Text] [Related]
15. CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.
Zimmerman DH; Taylor P; Bendele A; Carambula R; Duzant Y; Lowe V; O'Neill SP; Talor E; Rosenthal KS
Int Immunopharmacol; 2010 Apr; 10(4):412-21. PubMed ID: 20074669
[TBL] [Abstract][Full Text] [Related]
16. Induction of arthritis in SCID mice by T cells specific for the "shared epitope" sequence in the G3 domain of human cartilage proteoglycan.
Hanyecz A; Bárdos T; Berlo SE; Buzás E; Nesterovitch AB; Mikecz K; Glant TT
Arthritis Rheum; 2003 Oct; 48(10):2959-73. PubMed ID: 14558103
[TBL] [Abstract][Full Text] [Related]
17. Pan-DR-binding Hsp60 self epitopes induce an interleukin-10-mediated immune response in rheumatoid arthritis.
de Jong H; Lafeber FF; de Jager W; Haverkamp MH; Kuis W; Bijlsma JW; Prakken BJ; Albani S
Arthritis Rheum; 2009 Jul; 60(7):1966-76. PubMed ID: 19565483
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
19. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis.
Raptopoulou AP; Bertsias G; Makrygiannakis D; Verginis P; Kritikos I; Tzardi M; Klareskog L; Catrina AI; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2010 Jul; 62(7):1870-80. PubMed ID: 20506224
[TBL] [Abstract][Full Text] [Related]
20. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
